Stock Price Quote

JUPITER LIFE LINE HOSPITALS LTD.

NSE : JLHLBSE : 543980ISIN CODE : INE682M01012Industry : Hospital & Healthcare ServicesHouse : Private
BSE1324.90-10.4 (-0.78 %)
PREV CLOSE ( ) 1335.30
OPEN PRICE ( ) 1341.45
BID PRICE (QTY) 1324.85 (9)
OFFER PRICE (QTY) 1327.25 (1)
VOLUME 1552
TODAY'S LOW / HIGH ( )1321.90 1361.80
52 WK LOW / HIGH ( )960 1648.6
NSE1326.95-6.4 (-0.48 %)
PREV CLOSE( ) 1333.35
OPEN PRICE ( ) 1333.35
BID PRICE (QTY) 1326.95 (4)
OFFER PRICE (QTY) 1327.70 (2)
VOLUME 208032
TODAY'S LOW / HIGH( ) 1322.10 1364.50
52 WK LOW / HIGH ( )970 1653.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 2002
Management Info
Ajay Thakker - Chairman Ajay Thakker - Managing Director
Registered Office

Address 1004, 10th Floor, 360 Degree Business Park,Maharana Pratap Chowk, L B S Marg,Mulund (W),
Mumbai,
Maharashtra-400080

Phone 022-21725623

Email cs@jupiterhospital.com

Website www.jupiterhospital.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

17May Jupiter Life Line Hospitals informs ab
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
13May Jupiter Life Line Hospitals inches up
Jupiter Life Line Hospitals is currently trading at Rs. 1244.25, up by 4..
13May Jupiter Life Line Hospitals informs ab
Pursuant to Regulation 30 and Regulation 46(2) of SEBI (Listing Obligati..
11May Jupiter Life Line Hospitals gets nod f
Jupiter Life Line Hospitals has received approval for addition of 75 bed..
23Feb Jupiter Life Line acquires land in Pune
Jupiter Life Line Hospitals has acquired land in Bibvewadi, Pune, with a..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit431.471519.53
Gross Profit 590.14 2038.21
Operating Profit 651.262529.99
Net Sales 2453.139106.33

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6421.90 (1.07%)
M.Cap ( in Cr)91828.79
Dr Agarwals Eye Hsp (BSE)
peergroup  3300.20 (1.23%)
M.Cap ( in Cr)1553.66
Dr. Lal Pathlabs (BSE)
peergroup  2987.15 (1.26%)
M.Cap ( in Cr)25002.37
Narayana Hrudayalay (BSE)
peergroup  1252.15 (2.95%)
M.Cap ( in Cr)25593.13
Artemis Medicare (BSE)
peergroup  242.15 (11.85%)
M.Cap ( in Cr)3333.22

Shareholding Pattern

PROMOTERS 40.91%
NON-INSTITUTION 40.75%
MUTUAL FUNDS/UTI 13.28%
FI/BANKS/INSURANCE 0.54%
GOVERNMENT 0%
FII 0%

About Jupiter Life Line Hospitals Ltd.

Jupiter Life Line Hospitals Ltd. was incorporated in the year 2002. Its today's share price is 1324.9. Its current market capitalisation stands at Rs 8735.36 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7873.22 Cr and Total Income of Rs.8006.17 Cr. The company's management includes Suma Upparatti, Satish Utekar, Urmi Popat, Jasmin Patel, Vadapatra Raghavan, Bhaskar Shah, Ankit Thakker, Ajay Thakker, Ajay Thakker, Darshan Vora.

It is listed on the BSE with a BSE Code of 543980 , NSE with an NSE Symbol of JLHL and ISIN of INE682M01012. It's Registered office is at 1004, 10th Floor, 360 Degree Business Park,Maharana Pratap Chowk, L B S Marg,Mulund (W)Mumbai-400080, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Aswin P Malde & Co, BR Kotecha & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.